At a glance
What is it—and why does it matter?
Growth differentiation factor-11 (GDF-11) is classified within the transforming growth factor-β (TGF-β) superfamily. The study evaluated GDF-11 as one of the biomarkers intended to reflect regenerative signaling, measured in circulation and tissues in murine injury/senescence models.
Sources for this introduction: [1] [2]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
Growth differentiation factor-11 (GDF-11) is classified within the transforming growth factor-β (TGF-β) superfamily.
- Source records
- 2
- Independent studies
- 2
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“Growth differentiation factor-11 (GDF-11), a member of the transforming growth factor-β (TGF-β) superfamily”
Growth differentiation factor-11 stimulates human extravillous trophoblast cell invasion by upregulating Slug-mediated N-cadherin expression. · INTRODUCTION
pubmed:42097099:7f62be3927e7:7f62be3927e7 - supports · Source-backed record
“Growth differentiation factor 11 (GDF-11), a circulating member of the TGF-β superfamily”
GDF-11 triggers cold-induced browning and metabolic activation of adipose tissue. · OBJECTIVES
pubmed:42296290:3f173bf830e0:3f173bf830e0
How does it work?
Target, response, and disposition.
Mechanism
The study evaluated GDF-11 as one of the biomarkers intended to reflect regenerative signaling, measured in circulation and tissues in murine injury/senescence models.
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“Outcomes included biochemical and histologic indices of liver injury, circulating and tissue biomarkers of senescence (IL-11, YKL-40, IL-6, IL-23 R) and regeneration (Klotho, FGF-2, neo-VEGF, GDF-11),”
Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan. · METHODS
pubmed:42260530:23c65e1dc958:23c65e1dc958
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, regulatory, safety
- 44 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (39), assurance_score_below_0.72 (4), current_regulatory_source_required (2), extraction_ambiguity (43), high_risk_requires_regulatory_or_two_independent_sources (5), no_direct_support (43)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Growth differentiation factor-11 stimulates human extravillous trophoblast cell invasion by upregulating Slug-mediated N-cadherin expression. ↗
pubmed · published 2026-06-24 · retrieved 2026-08-26T20:13:52Z
- Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan. ↗
pubmed · published 2026-06-08 · retrieved 2026-08-26T20:13:52Z
- GDF-11 triggers cold-induced browning and metabolic activation of adipose tissue. ↗
pubmed · published 2026-06-16 · retrieved 2026-08-26T20:13:52Z
Publication history and provenance
Version 2 · Automated assessment · 2026-08-26T20:13:52Z
09f36c7c5c4294fbac91c1d4861182e2c013b23beb45e55629b505bd8b2dc1e9